文献速递肺结节与肺癌

快速现场细胞学评估对经支气管针吸活检诊断率影响的系统评价与Meta分析

Impact of Rapid On-Site Cytological Evaluation (ROSE) on the Diagnostic Yield of Transbronchial Needle Aspiration During Mediastinal Lymph Node Sampling: Systematic Review and Meta-Analysis.
PubMed 文献 · Chest · 2017-11-15

该系统评价与Meta分析纳入5项随机对照试验共618例纵隔淋巴结肿大患者,评估ROSE对c-TBNA或EBUS-TBNA诊断率的影响。结果显示ROSE未提高诊断率,但EBUS-TBNA中减少穿刺针数,c-TBNA中降低并发症率。

要点

  • ROSE未显著提高EBUS-TBNA或c-TBNA的诊断率。
  • EBUS-TBNA中使用ROSE可显著减少穿刺针数。
  • c-TBNA中使用ROSE与并发症率降低相关。

核心结论

  • ROSE未提高TBNA诊断率或缩短操作时间,但可减少EBUS-TBNA穿刺针数并降低c-TBNA并发症率。

研究设计与样本

  • 系统评价与Meta分析,纳入5项随机对照试验,共618例纵隔淋巴结肿大患者。

主要发现

  • EBUS-TBNA诊断率合并风险差为0.04(95%CI -0.01至0.09),c-TBNA为0.12(95%CI -0.08至0.33)。
  • EBUS-TBNA中使用ROSE显著减少穿刺针数,均数差为-1.1(95%CI -2.2至-0.005),P < .001。
  • c-TBNA中使用ROSE并发症率显著降低,OR为0.26(95%CI 0.10至0.71),P = .009。
  • EBUS-TBNA操作时间无差异,c-TBNA研究存在异质性,无发表偏倚。

临床怎么用

  • ROSE不宜以提升诊断率为目的常规使用,但可在EBUS-TBNA中减少穿刺针数、在c-TBNA中降低并发症率。

局限性

  • 纳入研究仅5项,c-TBNA相关研究存在异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether the use of rapid on-site cytologic evaluation (ROSE) increases the diagnostic yield of transbronchial needle aspiration (TBNA) remains unclear. This article is a systematic review of studies describing the utility of ROSE in subjects undergoing TBNA. METHODS: The study included a systematic review of the PubMed, Embase, and Scopus databases for randomized controlled trials investigating the diagnostic yield of conventional transbronchial needle aspiration (c-TBNA) or endobronchial ultrasound (EBUS)-TBNA, with or without ROSE, in subjects with mediastinal lymphadenopathy. RESULTS: Five studies (618 subjects; two EBUS-TBNA, two c-TBNA, and one both) were identified. Overall, the studies were of good quality. The pooled risk difference (95% CI) of the diagnostic yield of EBUS-TBNA and c-TBNA was 0.04 (-0.01 to 0.09) and 0.12 (-0.08 to 0.33), respectively, suggesting no added benefit with ROSE. The use of ROSE during EBUS-TBNA (but not c-TBNA) resulted in significantly fewer needle passes (mean difference [95% CI], -1.1 [-2.2 to -0.005]; P < .001). There was no difference in the procedure time during EBUS-TBNA. The complication rate was significantly lower (OR [95% CI], 0.26 [0.10 to 0.71]; P = .009) when ROSE was used during c-TBNA due to fewer additional procedures required to make a diagnosis. There was evidence of heterogeneity in the studies involving c-TBNA but not EBUS-TBNA. There was no publication bias. CONCLUSIONS: The use of ROSE neither improved the diagnostic yield nor reduced the procedure time during TBNA. However, the use of ROSE was associated with fewer number of needle passes during EBUS-TBNA and overall lower requirement for additional bronchoscopy procedures during TBNA to make a final diagnosis. TRIAL REGISTRY: PROSPERO; No.: CRD42017058937; URL: www.crd.york.ac.uk/prospero/.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Sehgal IS, Dhooria S, Aggarwal AN, et al. Impact of Rapid On-Site Cytological Evaluation (ROSE) on the Diagnostic Yield of Transbronchial Needle Aspiration During Mediastinal Lymph Node Sampling: Systematic Review and Meta-Analysis. Chest. 2017. PMID: 29154972. doi:10.1016/j.chest.2017.11.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。